Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

Presentation TCT 2024

TCT 467: Prolonged Occlusion of the Superior Vena Cava Using the PreCardia System Reduces Cardiac Filling and Renal Venous Pressures Without Causing Cerebral Injury in a Preclinical Model of Systemic Congestion

Presenter: Navin Kapur

October 28, 2024

News Daily News

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Todd Neale

October 21, 2024

News Daily News

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

Todd Neale

July 19, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Advertisement

November 2024 Dispatch for the CV Team

TCT 467: Prolonged Occlusion of the Superior Vena Cava Using the PreCardia System Reduces Cardiac Filling and Renal Venous Pressures Without Causing Cerebral Injury in a Preclinical Model of Systemic Congestion

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Debating the Role of T-TEER in the Sickest Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content